Table 2.
Gene | Mutation | Sequence | Consequence | Charge | Previously Reported Hypertrophic Cardiomyopathy Mutations |
---|---|---|---|---|---|
MYH7 | Lys146Asn | G→T | Missense | −1 | Yes |
MYH7 | Val606Met | G→A | Missense | 0 | Yes |
MYH7 | Arg663His | G→A | Missense | 0 | Yes |
MYH7 | Arg719Gln | G→A | Missense | −1 | Yes |
MYH7 | Val763Met | G→A | Missense | 0 | No |
MYH7 | Arg787Cys | C→T | Missense | −1 | No |
MYH7 | Leu908Val | C→G | Missense | 0 | Yes |
MYH7 | Glu924Lys | G→A | Missense | +2 | Yes |
MYH7 | Leu1414Met | C→A | Missense | 0 | No |
MYBPC3 | Gly278Glu | G→A | Missense | −1 | Yes |
MYBPC3 | Gly490Arg | G→A | Missense | +1 | Yes |
MYBPC3 | Arg495Gly | C→G | Missense | −1 | No |
MYBPC3 | Arg502Trp† | C→T | Missense | −1 | Yes |
MYBPC3 | Arg502Gln | G→A | Missense | −1 | Yes |
MYBPC3 | Asp605Asn | G→A | Missense | + 1 | Yes |
MYBPC3 | Arg943ter | C→T | Truncation | NA | Yes |
MYBPC3 | Thr1028Ser | C→G | Missense | 0 | No |
MYBPC3 | IVS31+2t→g‡ | t→g | Truncation | NA | No |
MYBPC3 | Gly1248Arg | G→a | Missense | + 1 | No |
TNNT2 | Arg92Gln | G→A | Missense | −1 | Yes |
TNNT2 | Glu96del | Δ GAG | Codon 96 deleted | + 1 | No |
TNNI3 | Lys178del | Δ AAG | Codon 178 deleted | −1 | Yes |
ACTC | His90Tyr | C→T | Missense | −1 | No |
ACTC | Arg97Cys | C→T | Missense | −1 | No |
PRKAG2 | His530Arg | A→G | Missense | 0 | No |
Mutations are denoted by normally encoded amino acid residue number, substituted amino acid or termination signal (ter), or altered splice signal (intervening sequence). Sequence refers to nucleotide substitution, and consequence refers to the mutational effects on protein. Charge is the altered charge by the mutant amino acid change. NA denotes not available. Three children had compound mutations: MYH7 Arg663His and MYH7 Val763Met, MYBPC3 Thr1028Ser and MYBPC3 IVS31+2t→g, and MYH7 Arg787Cys and ACTC Arg97Cys.
This mutation was identified in three children.
This mutation was identified in two children.